Keymed Biosciences Inc. (2162.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.15B |
| Enterprise Value | 13.4B |
| P/E Ratio | -27.82 |
| PEG Ratio | 0.4 |
| Price/Sales Ratio | 20.24 |
| Price/Book Ratio | 5.27 |
| Enterprise/Revenue | 20.59 |
| Enterprise/EBITDA | -28.39 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.72 |
| Operating Margin | -0.83 |
AD
Management Effectiveness
| Return On Assets | -0.12 |
| Return On Equity | -0.17 |
Income Statement
| Revenue | 697.77M |
| Revenue/Share | 2.39 |
| Gross Profit | 516.51M |
| EBITDA | -489.36M |
| Net Income | -509.11M |
| Diluted EPS | -1.86 |
Balance Sheet
| Total Cash | 1.96B |
| Total Cash/Share | 6.58 |
| Total Debt | 788.88M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 2.9 |
| Book Value Per Share | 9.29 |
Price History
| 52-Week Change | 22.86 |
| 52-Week High | 81.85 |
| 52-Week Low | 43.8 |
| Moving Average 50 Days | 67.36 |
| Moving Average 200 Days | 62.06 |
Statistics
| Average Volume | 2.6M |
| Shares Outstanding | 294.6M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
